By Hailey Konnath (March 10, 2022, 10:06 PM EST) -- The Ninth Circuit on Thursday declined to resurrect whistleblower accusations that McKesson Corp. falsely told the government that it complied with security protocols to stop opioid diversion, agreeing with a California federal court that the allegations don't meet the standards established by the U. S. Supreme Court's landmark Escobar decision. The three-judge panel upheld the district court's dismissal of the False Claims Act suit brought by a pair of former McKesson employees. The federal magistrate judge overseeing the case had pointed to the Escobar decision and successive Ninth Circuit case law in finding that the employees hadn't alleged enough specifics as to. . .
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
- Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
- Create custom alerts for specific article and case topics and so much more!
Read Full Story:
https://www.law360.com/lifesciences/articles/1472873/9th-circ-won-t-revive-mc...